224 Results (Page 8 of 9)
Australia Markets Research Reports
Australia Acne Therapeutics Market Analysis
Australia's acne therapeutics market is expected to grow from $120 Mn in 2022 to $226 Mn in 2030 with a CAGR of 8.2% for the forecasted year 2022-2030. More than 90% of Australian teenagers suffer from acne vulgaris which leads to the increasing demand for acne treatment options in Australia thereby driving the growth of Australia's acne therapeutics market. The market is segmented by treatment, route of administration, age group, and by distribution channel. Some of the major players in the Australian acne therapeutics market are Sypharma, BioDiem, and Novan.
Australia Anti Aging Therapeutics Market Analysis
Australia's anti-ageing therapeutics market is projected to grow from $7 Mn in 2022 to $27 Mn in 2030 with a CAGR of 18.03% for the year 2022-2030. The increasing elderly population and innovative technological advancements in Australia are responsible for the growth of the market. The Australian anti-ageing therapeutics market is segmented by product, treatment, target group, type of ageing, type of molecules, mechanism of action, ingredient, and by distribution channel. Clinuvel Pharmaceuticals, EZZ Life Science, and PharmatrophiX are the major competitors in the market.
Australia In Vitro Fertilisation (IVF) Service Market Analysis
This report presents a strategic analysis of Australia In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about Australia In Vitro Fertilisation (IVF) Service Market, offering unmatched value, accuracy and expert insights.
Australia Teleradiology Market Analysis
Australia's Teleradiology market size was valued at $28 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 13.2% from 2022 to 2030 and will reach $ 77 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The Australian teleradiology market will grow due to Increasing demand for remote radiology services. The key market players are Vision Radiology, Imaging Central, Global Diagnostics, I-MED Radiology Network and others.
Australia Artificial Intelligence (AI) in Healthcare Market Analysis
Australia's Artificial Intelligence (AI) in the healthcare market is projected to grow from $0.08 Bn in 2022 to $1.78 Bn by 2030, registering a CAGR of 46.72% during the forecast period of 2022-30. The market will be driven by the increasing demand for efficient and effective healthcare delivery and the availability of healthcare data. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Google Health, HealthMatch & Clevertar.
Australia Healthcare Insurance Market Analysis
Australia's healthcare insurance market is projected to grow from $24.31 Bn in 2022 to $48.81 Bn by 2030, registering a CAGR of 9.1% during the forecast period of 2022-2030. The main factors driving the growth would be government policies, increasing awareness, rising healthcare costs and the growing geriatric population. The market is segmented by component, the provider, coverage, health insurance plans and end-user. Some of the major players include Pheonix Health fund, NIB, HBF, St. Lukes's and Latrobe.
Australia Artificial Intelligence (AI) in Medical Imaging Market Analysis
Australia artificial intelligence (AI) in medical Imaging market size was valued at $18 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 36.9% from 2022 to 2030 and will reach $222 Mn. The market is segmented by AI technology, solution, modality, application, and end User. Due to rowing demand for advanced healthcare solutions, the demand for AI in medical imaging is rising across the Australia market. Some of the key players in this market are Harrison.ai (AUS), MaxQ AI (AUS), LBT Innovations (AUS), 4Dx Limited (AUS), Oneview Healthcare (AUS), Siemens Healthineers, GE Healthcare, Philips Healthcare, Fujifilm Holdings Corporation, Canon Medical Systems Australia, and others.
Australia Physiotherapy Market Analysis
The physiotherapy market in Australia is a growing industry currently valued at $638 Mn in 2022, and the market is estimated to grow to $1,126 Mn at a CAGR of 7.35% for the forecasted period 2022-30. With the increasing demand for physiotherapy services due to an ageing population of over 4.5 Mn and an increase in chronic conditions such as obesity and diabetes. The skyward growth trend is sustained by major players like CPL, Spinal Life Australia, and APE Medical Physiotherapy Equipment.
Australia Biosimilars Market Analysis
Australia biosimilars market size was valued at $230 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 23.7% from 2022 to 2030 and will reach $1263 Mn in 2030. The market is segmented by product type and indication type. The Australian Biosimilars market will grow as there is a shortage of qualified radiologists and imaging technologists in some areas, leading to longer wait times and delays in diagnosis and treatment. The key market players are Sonic Healthcare Limited Amgen, Biocon, Celltrion Healthcare, Dr. Reddy's Laboratories, and others.
Australia 3D Imaging Market Analysis
Australia's 3D imaging market is projected to grow from $ 0.36 Bn in 2022 to $ 1.37 Bn by 2030, registering a CAGR of 18% during the forecast period of 2022-30. The market will be driven by the rising chronic illness incidence and the increasing demand for less invasive treatments. The market is segmented by product, application, end-user & by portability. Some of the major players include GE Healthcare, Philips Healthcare, Siemens Healthineers & Australian imaging.
Australia ECG Equipments Market Analysis
The Australia ECG Equipment Market is expected to witness growth from $107 Mn in 2022 to $210 Mn in 2030 with a CAGR of 8.80% for the forecasted year 2022-2030. The Australian government has recently increased healthcare spending, which is likely to fuel market expansion for ECG equipment. The market is segmented by product type and by the end user. Some key players in this market include Tomlin Medical, Anatomics, Johnson & Johnson, Philipps Healthcare, Medtronic, Biolight and Dexcom.
Australia Women's Health Market Analysis
Australia women’s health market is projected to grow from $479 Mn in 2022 to $781 Mn by 2030, registering a CAGR of 6.30% during the forecast period of 2022-30. The Australian government has implemented a number of policies and programs aimed at promoting women's health, such as providing funding for cancer screenings and research on women's health issues through the Medicare Benefits Schedule (MBS). Companies such as Pfizer, AstraZeneca, and GlaxoSmithKline are major players in the Australia women's health market, producing drugs and supplements for conditions such as osteoporosis and menopause.
Australia 3D Printing Medical Devices Market Analysis
Australia's 3D printing medical devices market size was valued at $36 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $132 Mn in 2030. The market is segmented by component, application, technology, and end user. The Australia 3D Printing Medical Devices market will grow as 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. The key market players are Some of the key players in the market include Anatomics, Osteopore, MELD Manufacturing Corporation, 3D Medical Limited, Stratasys, Materialise, Stryker, and others.
Australia Depression Therapeutics Market Analysis
The Australian depression therapeutics market is expected to witness growth from $121 Mn in 2022 to $204 Mn in 2030 with a CAGR of 6.7% for the forecasted year 2022-2030. The development of newer and innovative therapeutics by Australian pharmaceutical companies and the increased demand for personalized depression treatment in Australia are driving the growth of the market. The Australian depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Kira Biotech, Zucero Therapeutics, and Pfizer are the major players in the Australian depression therapeutics market.
Australia Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Australia liver cancer therapeutics market will reach a value of $142.3 Mn from $35.2 Mn in 2022, growing at a CAGR of 19.1% during 2022-30. Liver cancer therapeutics in Australia is dominated by a few domestic pharmaceutical companies such as Imugene Limited, Kazia Therapeutics, and Sirtex Medical Limited. Liver cancer therapeutics in Australia is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Australia Cardiac Surgery Instruments Market Analysis
The Australian Cardiac Surgery Instruments Market is expected to witness growth from $25 Mn in 2022 to $46 Mn in 2030 with a CAGR of 8.10% for the forecasted year 2022-2030. In Australia, the demand for minimally invasive surgical instruments, like endoscopes and laparoscopic instruments, is anticipated to increase in the Australian healthcare market as patients there seek out less invasive surgical choices that reduce scarring and recovery time. The market is segmented by type, application and by end user. Some key players in this market include Fairmont Medical Products, Rowe Medical Supplies, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Australia Healthcare Claims Management Market Analysis
The Australian healthcare claims management market is projected to grow from $320.4 Mn in 2022 to $1897.54 Mn by 2030, registering a CAGR of 24.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be an increase in healthcare provider consolidation, technological advancements, regulatory changes and an increase in healthcare spending. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include Proclaim, Medibank, Riskware, Cognizant and Accenture.
Australia ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Australia's ADHD therapeutics market is expected to witness growth from $355 Mn in 2022 to $707 Mn in 2030 with a CAGR of 9% for the year 2022-30. The increasing prevalence of ADHD in Australia and the rise in demand for innovative treatment options for its treatment and more investments by pharmaceutical companies in ADHD drugs are the potential growth drivers for the market. The Australia ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Zucero Therapeutics, Atherton Pharmaceuticals, and Novartis are the major players operating in the market.
Australia Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Australia Liver Disease Therapeutics market will reach a value of $483 Mn from $277 Mn in 2022, growing at a CAGR of 7.2% during 2022-2030. Liver Disease Therapeutics in Australia is dominated by a few domestic pharmaceutical companies such as Aspen Pharmacare Australia, Mayne Pharma, and Phebra. The Liver Disease Therapeutics market in Australia is segmented into different types of disease and different therapy types. Some of the major factors affecting the Australian Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Australia Oncology Clinical Trials Market Analysis
Australia's oncology clinical trials market is projected to grow from $151.8 Mn in 2022 to $260.8 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022-30. The market will be driven by the rising investment in clinical research, increased patient education and engagement, and the development of new and innovative clinical trial designs. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis International AG, AstraZeneca plc & Kazia Therapeutics Limited.
Australia Diabetes Drugs Market Analysis
The Australia diabetes drugs market size was valued at $0.74 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.6% from 2022 to 2030 and will reach $1.33 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The Australia diabetes drug market will grow because of the high prevalence of diabetes in the country, which creates a significant demand for medications to manage the disease. The key market players are CSL Limited, AstraZeneca, Novo Nordisk, Sanofi, and others.
Australia Alexipharmic Drugs Market Analysis
Australia's Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 6.20% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The rising incidence of poisonings due to accidental or intentional exposure to toxins is driving the demand for alexipharmic drugs in Australia. The key market players are CSL Behring, Hospira, Mylan, Phebra (AUS), and others.
Australia Neurology Clinical Trials Market Analysis
The Australia Neurology Clinical Trials market is projected to grow from $62.8 Mn in 2022 to $107.8 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by internationally competitive government subsidies for R&D investment and a well-developed infrastructure to support clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Biogen Inc, Neuroscience Trials Australia & Prana Biotechnology Limited.
Australia Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Australia infectious disease therapeutics market will reach a value of $2.27 Bn from $1.44 Bn in 2022, growing at a CAGR of 5.9% during 2022-2030. Infectious Disease Therapeutics in Australia is dominated by domestic pharmaceutical companies such as AdAlta, Starpharma and CSL. The Infectious Disease Therapeutics market in Australia is segmented into different therapeutic areas and different diseases type. The major factors affecting the Australia infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various of areas of Australia.
Australia Clinical Diagnostics Market Analysis
Australia's clinical diagnostic market was valued at $827 Mn in 2022 and is estimated to expand at a CAGR of 7.5% from 2022 to 2030 and will reach $1475 Mn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, Australian Clinical Labs, Healthscope Limited, Primary Health Care Limited, Sonic Healthcare, Healius, Austech Medical Laboratories, I-Med Radiology Network, and others.